Acutus Medical (AFIB)
(Delayed Data from OTC)
$0.04 USD
+0.01 (19.63%)
Updated Sep 11, 2024 10:50 AM ET
NA Value
NA Growth NA Momentum NA VGMBalance Sheet
Fiscal Year End for Acutus Medical, Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 29 | 76 | 101 | 131 | 72 |
Receivables | 11 | 21 | 4 | 2 | 0 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 4 | 13 | 16 | 13 | 8 |
Other Current Assets | 1 | 7 | 5 | 5 | 2 |
Total Current Assets | 46 | 118 | 126 | 151 | 82 |
Net Property & Equipment | 1 | 9 | 14 | 12 | 4 |
Investments & Advances | 0 | 0 | 7 | 9 | 0 |
Other Non-Current Assets | 4 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 0 | 2 | 17 | 18 | 16 |
Deposits & Other Assets | 0 | 1 | 1 | 1 | 0 |
Total Assets | 54 | 133 | 170 | 193 | 105 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 3 | 5 | 8 | 8 | 4 |
Current Portion Long-Term Debt | 2 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 3 | 10 | 9 | 7 | 10 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 11 | 5 | 2 | 5 | 17 |
Total Current Liabilities | 19 | 20 | 19 | 22 | 32 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 33 | 34 | 40 | 39 | 38 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 0 | 0 | 1 | 4 | 6 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 55 | 58 | 64 | 66 | 78 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 253 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 600 | 594 | 585 | 487 | 33 |
Retained Earnings | -600 | -518 | -479 | -361 | -259 |
Other Equity | -1 | -1 | 0 | 0 | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | -1 | 75 | 106 | 127 | 28 |
Total Liabilities & Shareholder's Equity | 54 | 133 | 170 | 193 | 105 |
Total Common Equity | -1 | 75 | 106 | 127 | -226 |
Shares Outstanding | 29.30 | 28.40 | 27.90 | 27.80 | NA |
Book Value Per Share | -0.03 | 2.64 | 3.79 | 4.55 | 0.00 |
Fiscal Year End for Acutus Medical, Inc falls in the month of December.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 13 | 20 | 29 | 45 | 62 |
Receivables | 9 | 8 | 11 | 9 | 8 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 5 | 6 | 4 | 16 | 16 |
Other Current Assets | 1 | 1 | 1 | 2 | 2 |
Total Current Assets | 28 | 34 | 46 | 73 | 87 |
Net Property & Equipment | 1 | 1 | 1 | 7 | 7 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 3 | 3 | 4 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 0 | 0 | 0 | 1 | 1 |
Deposits & Other Assets | 0 | 0 | 0 | 1 | 1 |
Total Assets | 35 | 42 | 54 | 85 | 100 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 2 | 3 | 3 | 5 | 5 |
Current Portion Long-Term Debt | 7 | 2 | 2 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 2 | 2 | 3 | 7 | 10 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 1 | 2 | 11 | 2 | 3 |
Total Current Liabilities | 12 | 10 | 19 | 15 | 18 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 25 | 33 | 33 | 35 | 35 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 0 | 0 | 0 | 0 | |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 40 | 46 | 55 | 53 | 57 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 599 | 598 | 600 | 599 | 598 |
Retained Earnings | -603 | -602 | -600 | -566 | -553 |
Other Equity | -1 | -1 | -1 | -1 | -1 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | -5 | -4 | -1 | 32 | 44 |
Total Liabilities & Shareholder's Equity | 35 | 42 | 54 | 85 | 100 |
Total Common Equity | -5 | -4 | -1 | 32 | 44 |
Shares Outstanding | 29.70 | 29.70 | 29.30 | 29.20 | 28.90 |
Book Value Per Share | -0.16 | -0.14 | -0.03 | 1.09 | 1.51 |